Clinical Trial Update: Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) Relapses [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oral methylprednisolone versus intravenous methylprednisolone for treatment of relapses in relapsing-remitting multiple sclero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Methylprednisolone (intravenous) (methylprednisolone)
• Methylprednisolone (oral) (methylprednisolone)

Snippet

Sponsor: Rennes University Hospital | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 3 | Status: UNKNOWN